$126.30
-1.12-0.88%
Last update: Nov 5, 11:42 AM
Haemonetics Corp
HAENYSE
Haemonetics (HAE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Haemonetics (HAE) last issued guidance on November 5, 2026 for fiscal year 2027. The company guided revenue in the range of $1.44B - $1.48B for the period.
Compared to prior guidance, Haemonetics raised its revenue forecast from a prior range of $1.4B - $1.44B.
Haemonetics has issued 18 guidance updates between November 7, 2022 and November 5, 2026. During this period, the company raised its outlook 10 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q2 '27 | Q1 '27 | Q4 '26 | Q3 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.29 | $1.09 | $1.27 | $1.26 |
| Actual | $1.35 | $1.14 | $1.29 | $1.31 |
| Surprise | +4.65% | +4.59% | +1.57% | +3.97% |
| Revenue | ||||
| Estimate | $345.5M | $329.2M | $337.1M | $333.3M |
| Actual | $357.8M | $339.4M | $346.4M | $339.0M |
| Surprise | +3.55% | +3.10% | +2.74% | +1.70% |
| Metric | Q3 '27E | Q4 '27E | Q1 '28E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $1.36 | $1.48 | $1.26 |
| Revenue | |||
| Consensus | $357.6M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Nov 5, 2026 | $1.35 | $1.29 | 4.65 % |
| Q1 | Aug 6, 2026 | $1.14 | $1.09 | 4.59 % |
| Q4 | May 7, 2026 | $1.29 | $1.27 | 1.57 % |
| Q3 | Feb 5, 2026 | $1.31 | $1.26 | 3.97 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Nov 5, 2026 | $357.76M | $345.48M | 3.55 % |
| Q1 | Aug 6, 2026 | $339.38M | $329.19M | 3.10 % |
| Q4 | May 7, 2026 | $346.35M | $337.12M | 2.74 % |
| Q3 | Feb 5, 2026 | $338.97M | $333.30M | 1.70 % |
